Skip to main content

biovu Archives

Fibromyalgia: More doctor visits mean fewer suicide attempts

Sep. 20, 2018—Fibromyalgia patients who regularly visit their physicians are much less likely to attempt suicide than those who do not, according to a new Vanderbilt University Medical Center study published in Arthritis Care & Research.

Read more


VUMC drug repurposing initiative gaining momentum

Apr. 19, 2018—Drug repurposing involves establishing an additional approved indication for a drug already at market.

Read more


Nashville Biosciences created to leverage wealth of data

Apr. 5, 2018—Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

Read more


Grant bolsters study of potential new therapy for C. diff infection

Mar. 22, 2018—According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.

Read more


Study spots undiagnosed genetic diseases in EHR

Mar. 15, 2018—Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases.

Read more


Cannabis compound reduces seizures

Feb. 26, 2018—Cannabidiol (CBD) oils reduced seizures in patients with difficult-to-treat epilepsy, Vanderbilt investigators have found.

Read more


BioVU focus of Research Enterprise Forum Jan. 31

Jan. 10, 2018—The School of Medicine will host a Research Enterprise Forum from 3 to 4 p.m. Wednesday, Jan. 31.

Read more


BioVU anniversary

Feb. 23, 2017—Last week the BioVU Operations Oversight Board celebrated the 10-year anniversary of the launching of BioVU, Vanderbilt University Medical Center’s massive biobank.

Read more


Rheumatoid subtypes explored by PheWAS

Oct. 7, 2016—A computer-based method pioneered at Vanderbilt is being used to compare subtypes of rheumatoid arthritis.

Read more


VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Jul. 7, 2016—Vanderbilt University Medical Center has been chosen by the National Institutes of Health to be a leader in a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people. The NIH will provide $71.6 million over five years to VUMC, making this the largest research grant the Medical Center has ever received from any source.

Read more


VUMC chosen for leadership role in NIH Precision Medicine Initiative Cohort Program

Jul. 7, 2016—Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced.

Read more


VUMC and Celgene Corporation enter into research agreement to accelerate development of next-generation therapeutics

Apr. 4, 2016—Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more